gastric inhibitory polypeptide
Peptideexperimental
Gastric inhibitory polypeptide (GIP), also known as glucose-dependent insulinotropic polypeptide, is an inhibiting hormone of the secretin family of hormones. While it is a weak inhibitor of gastric acid secretion, its main role, being an incretin, is to stimulate insulin secretion. — Wikipedia
Clinical trial activity
11 trials · 9 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2003 (NCT00239707)
Timeline
2000s
- Jan 1, 2003
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
GIP agonist
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
Also known as
- gastric inhibitory polypeptide
- glucose dependent insulinotropic polypeptide
- glucose-dependent insulinotropic polypeptide
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03556098 | N/A | Oct 1, 2018 | Steno Diabetes Center Copenhagen |
| NCT02550548 | Phase 1 | Apr 21, 2016 | Duke University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
| NCT02370745 | N/A | Nov 1, 2014 | University of Nottingham |
| NCT01851694 | N/A | May 1, 2013 | University of Pennsylvania |
| NCT01749163 | N/A | Sep 1, 2012 | University of Copenhagen |
| NCT01048268 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2009 | University of Copenhagen |
| NCT00949663 | Phase 1 | Oct 1, 2009 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Washington University in St. Louis |
| NCT00798915 | Phase 1 | Dec 1, 2008 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Washington University in St. Louis |
| NCT00612950 | N/A | Oct 1, 2006 | University of Copenhagen |
| NCT02673554 | Phase 1 | May 1, 2004 | Diabeteszentrum Bad Lauterberg |
| NCT00239707 | Phase 1 | Feb 1, 2003 | National Institute on Aging (NIA) |
Showing 11 of 11 trials
Page 1 / 1
Organizations
Research & Development (9)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Government | 3 | 0 | 1 | 2008 |
| University of Copenhagen | Academic/Hospital | 3 | 3 | 2 | 2006 |
| Washington University in St. Louis | Academic/Hospital | 2 | 2 | 1 | 2008 |
| Diabeteszentrum Bad Lauterberg | Academic/Hospital | 1 | 1 | 1 | 2004 |
| Duke University | Academic/Hospital | 1 | 1 | 1 | 2016 |
| National Institute on Aging (NIA) | Government | 1 | 1 | 1 | 2003 |
| Steno Diabetes Center Copenhagen | Academic/Hospital | 1 | 1 | 1 | 2018 |
| University of Nottingham | Academic/Hospital | 1 | 1 | 1 | 2014 |
| University of Pennsylvania | Academic/Hospital | 1 | 1 | 1 | 2013 |
9 organizations
Page 1 / 1